Caitong International Asset Management Co., LTD Cullinan Oncology, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 401 shares of CGEM stock, worth $2,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401Holding current value
$2,903% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGEM
# of Institutions
154Shares Held
68.5MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$55.4 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$41.6 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$28 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$25.7 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$24.7 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $330M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...